After an unsuccessful WHO inspection, Panacea Biotech sought assistance from PCS to enhance their WHO GMP quality system. Through prompt remediation and interim corporate Quality Assurance services over several years, PCS aided Panacea in restoring its previous level of GMP standards, enabling the company to resume the production and delivery of various vaccine products to the WHO.
